HKG · EQUITY · ENHANCED MARKET DYNAMICS
0455
Tianda Pharmaceuticals LimitedHK · Healthcare · Drug Manufacturers - Specialty & Generic
CURRENT COMPLETED-WEEK READ
Constructive
The balance of evidence is supportive, with some confirmation still incomplete. Conditions are positive and have strengthened over the latest four completed weeks.
- Completed week
- 28 Aug 2026
- Latest close
- HKD 0.111
- Evidence
- 156 weeks
COMPLETED-WEEK OVERVIEW
Price and market conditions over time
4 supportive · 1 cautious
THE FULL PRICE CYCLE
Follow the journey from one zone to the other
Each state uses completed-week information available at that point.
Lower zone
Price establishes residence near the bottom of its long-cycle range. Improving EMD separates early repair from continued deterioration.
Upward journey
Price leaves the lower zone while EMD confirms improving participation. The objective is the broader move toward the upper zone, not a short weekly trade.
Upper zone
Price establishes residence near the top of its long-cycle range. This is the profit-harvest area, with EMD watched for exhaustion and loss of support.
Downward journey
Price leaves the upper zone while EMD weakens. The reverse cycle remains active until lower-zone residence is confirmed again.
CURRENT READINGS
What the latest week shows
Completed-week values
01
Underlying pressure
Strengthening beneath price
4-week change +0.45
02
Trend and deviation
Price structure supports the trend
Trend gate inactive
03
Momentum and SMI
Momentum is supportive
SMI 0.30
04
Price-volume pressure
Volume is leaning against the close
Volume ratio 0.90x
05
Relative leadership
The ticker is lagging its benchmark
4-week change +11.76
06
Modeled Trend
Modeled Trend is supportive
Smoothed Modeled Trend 0.25